Richard J. Benjamin - 01 Mar 2022 Form 4 Insider Report for CERUS CORP (CERS)

Role: Chief Medical Officer
Signature: Richard J. Benjamin by Chrystal Menard, attorney-in-fact
Issuer symbol: CERS
Transactions as of: 01 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2022, 18:36:21 UTC
Previous filing: 05 Nov 2021
Next filing: 15 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CERS	Restricted Stock Unit	Award	$0	+52,500	+69%	$0.000000	128,535	01 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CERS	Option (Right to Buy)	Award		+105,000			105,000	01 Mar 2022	Common Stock	105,000	$5.76	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
F2	One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter.
F3	Not applicable.